Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for radiation-induced pain flare in bone metastases
NCT01248585Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- May 2011
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in bone metastases, sponsored by Canadian Cancer Trials Group. Primary endpoint: Radiation-induced Pain Flare Incidence at 10 days. Started May 2011; status: completed.
02
Drugs
dexamethasone
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT01248585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248585.